Navigation Links
Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Date:3/13/2013

te of MACE in the Light Study, the timing of approval for Contrave, the submission of a Contrave application for marketing authorization in Europe and the negotiation of a partnership for the rest-of-world rights to Contrave and Empatic, the expected cash usage for the year 2013, the development of Empatic and the communication with the FDA, the possibility that a cardiovascular outcomes trial will be needed for Empatic, and the commercial potential of Contrave and Empatic. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: Orexigen's ability to conduct the Light Study and the progress and timing thereof; Orexigen's ability to demonstrate in the Light Study that the risk of MACE in overweight and obese subjects treated with Contrave does not adversely affect the product candidate's benefit-risk profile; the potential that earlier clinical trials or analyses (such as the interim analysis) may not be predictive of future results in the Light Study or Phase 3 trials for Empatic; the Special Protocol Assessment (SPA) is not binding on the FDA if public health concerns unrecognized at the time the SPA agreement was entered into become evident, other new scientific concerns regarding product safety or efficacy arise, or if Orexigen fails to comply with the agreed upon trial protocol; the potential for the FDA to not approve Contrave or Empatic; the potential for early termination of the collaboration agreement between Orexigen and Takeda; the costs and time required to complete additional clinical, non-clinical or other requirements prior to any resubmission of an NDA for Contrave or an NDA for Empatic; the therapeutic and commercial value of Contrave or Empatic; Orexigen's ability to maintain sufficient capital; and other ri
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... NEW YORK , April 24, 2015 /PRNewswire/ ... Diseases (NIAID) (part of the National Institutes of ... million to nine research projects for the development ... light of  recent HAI outbreaks at U.S. health ... are supporting research into rapid, multiplexed and effective ...
(Date:4/24/2015)... , April 24, 2015  Elekta has CE ... Monaco® treatment planning system , enabling European clinics to ... major treatment techniques including advanced 3D planning, IMRT, VMAT ... Monaco ® ... well improved workflow efficiency. Advancements in 3D planning as ...
(Date:4/23/2015)... , April 23, 2015 Once again, BeaconMedaes ... our commitment to patient safety. BeaconMedaes, priority ... against infectious disease. The next generation Zone ... gas sensors are now mounted in the assembly, allowing ... to open ceiling tiles potentially releasing dust spores and ...
Breaking Medicine Technology:Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Elekta CE marks for Monaco v5.10 treatment planning system 2BeaconMedaes launches new Zone Valve Box Assembly 2
(Date:4/26/2015)... CA (PRWEB) April 26, 2015 In an ... Washington State University evaluated the head-neck biomechanics occurring during the ... the study were able to determine that use of a ... as 3 to 5 times - more than when the ... outcome for such a study, but pointing out the potential ...
(Date:4/26/2015)... TN (PRWEB) April 26, 2015 ... to grow throughout the Southeast. MidSouth Pain Treatment Center ... locations in Cordova, Southaven, Oxford and Jackson, two ambulatory ... laboratory in the Southaven and Cordova locations. , ... ”I went into medicine to help people, and ...
(Date:4/25/2015)... April 26, 2015 Avid Collector Andrew ... 1965 Rolling Stones Greensboro Coliseum concert posters. The concert ... of the Stone's Second American Tour. , According ... Company out of Baltimore, Maryland. This poster blank was ... and southern cites. Globe uses garish lettering and colors ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 In the ... twelve and above needed treatment for an illicit ... the Substance Abuse and Mental Health Services Administration’s Survey ... Beyond these alarming numbers are harrowing stories of men ... substance abuse . David H. Kerr , founder ...
(Date:4/25/2015)... By definition, a CIO’s responsibility is to ... relying on their judgement and expertise to keep digital assets ... an article published in National Mortgage News on April ... a disservice to their responsibilities by focusing too heavily on ... crossed when it comes to company policy and industry best ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5
... - Contract Extended One Year -LEXINGTON, Mass., Jan. ... MedAssets Supply Chain Systems has extended its contract ... 2010. This continues a successful history between ... in 2002.The contract covers IL,s portfolio of critical ...
... Medimetriks Pharmaceuticals announced today that the Company ... (Nasdaq: PRGO ), a leading manufacturer in ... Authorized Distributor of generic versions of Medimetriks, branded products ... to receive a percentage of Perrigo,s Net Sales on ...
... HEIGHTS, N.J., Jan. 26 Authentidate Holding Corp. ... of secure Health Information Exchange and workflow management ... from representatives of Parascript, LLC and Parascript Management, ... Agreement and Plan of Merger it entered into ...
... standards snag company awardIRVINE, Calif., Jan. 26 ... in phytochemical reference standards and contract research, announced ... natural products and alternative health care magazine, selected ... Scientific Achievement Award recipients for its achievement in ...
... 26 Trintech Group Plc (Nasdaq: TTPA ... transaction risk management, and compliance solutions, today announced that ... meet on January 27 in Mountain View, California as ... share common experiences, discuss the latest market trends and ...
... announced,that it has launched the International College ... surgical teams from around the world.,The launch was announced ... San Francisco. , "We have ... we began our program in 2002," says Kirk Wilson, ...
Cached Medicine News:Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 2Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 3Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 2Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 3Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 2Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 3Health News:ChromaDex Awarded Nutrition Business Journal Scientific Achievement 2Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 2Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 3Health News:Saint Joseph's Launches International College of Robotic Surgery 2
Replacement gaskets for the Empore 96 Well Vacuum Manifold Assembly, insure a tight seal....
DNA/RNA preparation in 96-well format...
... units with hydrophobic PTFE membranes,Millex filter ... ideal for the sterilizing filtration of ... and for sterilizing or clarifying organic ... filter units are available with different ...
... Undercounter refrigerator -4C. 5.2 ... reversible. Interior light. Manual ... see-through drawers. Two shelves. ... bottles. Adjustable thermostat. Magnetic ...
Medicine Products: